A Study to Investigate APL-4098 Alone and in Combination in Adults With AML or MDS

Clinical trial NCT06372717 · RECRUITING

Trial details

NCT number: NCT06372717
Sponsor: Apollo Therapeutics Ltd
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Refractory Myelodysplastic Syndrome Acute Myeloid Leukemia Myelodysplastic Syndrome With Excess Blasts Acute Myeloid Leukemia, in Relapse Acute Myeloid Leukemia (AML)

Start date: 2024-06-04
Primary completion: 2027-03-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.